MLANA

Revision as of 19:18, 4 September 2012 by WikiBot (talk | contribs) (Robot: Automated text replacement (-{{WikiDoc Cardiology Network Infobox}} +, -<references /> +{{reflist|2}}, -{{reflist}} +{{reflist|2}}))
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)
Jump to navigation Jump to search


Melan-A
Identifiers
Symbols MLANA ; MART-1; MART1
External IDs Template:OMIM5 Template:MGI HomoloGene4026
RNA expression pattern
File:PBB GE MLANA 206426 at tn.png
File:PBB GE MLANA 206427 s at tn.png
More reference expression data
Orthologs
Template:GNF Ortholog box
Species Human Mouse
Entrez n/a n/a
Ensembl n/a n/a
UniProt n/a n/a
RefSeq (mRNA) n/a n/a
RefSeq (protein) n/a n/a
Location (UCSC) n/a n/a
PubMed search n/a n/a

Melan-A, also known as MLANA, is a human gene.[1]


References

  1. "Entrez Gene: MLANA melan-A".

Further reading

  • Coulie PG, Brichard V, Van Pel A; et al. (1994). "A new gene coding for a differentiation antigen recognized by autologous cytolytic T lymphocytes on HLA-A2 melanomas". J. Exp. Med. 180 (1): 35–42. PMID 8006593.
  • Kawakami Y, Eliyahu S, Delgado CH; et al. (1994). "Cloning of the gene coding for a shared human melanoma antigen recognized by autologous T cells infiltrating into tumor". Proc. Natl. Acad. Sci. U.S.A. 91 (9): 3515–9. PMID 8170938.
  • Zippelius A, Pittet MJ, Batard P; et al. (2002). "Thymic selection generates a large T cell pool recognizing a self-peptide in humans". J. Exp. Med. 195 (4): 485–94. PMID 11854361.
  • Moritake H, Sugimoto T, Asada Y; et al. (2002). "Newly established clear cell sarcoma (malignant melanoma of soft parts) cell line expressing melanoma-associated Melan-A antigen and overexpressing C-MYC oncogene". Cancer Genet. Cytogenet. 135 (1): 48–56. PMID 12072203.
  • Dutoit V, Rubio-Godoy V, Pittet MJ; et al. (2002). "Degeneracy of antigen recognition as the molecular basis for the high frequency of naive A2/Melan-a peptide multimer(+) CD8(+) T cells in humans". J. Exp. Med. 196 (2): 207–16. PMID 12119345.
  • Mantovani S, Palermo B, Garbelli S; et al. (2002). "Dominant TCR-alpha requirements for a self antigen recognition in humans". J. Immunol. 169 (11): 6253–60. PMID 12444131.
  • Strausberg RL, Feingold EA, Grouse LH; et al. (2003). "Generation and initial analysis of more than 15,000 full-length human and mouse cDNA sequences". Proc. Natl. Acad. Sci. U.S.A. 99 (26): 16899–903. doi:10.1073/pnas.242603899. PMID 12477932.
  • Du J, Miller AJ, Widlund HR; et al. (2003). "MLANA/MART1 and SILV/PMEL17/GP100 are transcriptionally regulated by MITF in melanocytes and melanoma". Am. J. Pathol. 163 (1): 333–43. PMID 12819038.
  • Mandelcorn-Monson RL, Shear NH, Yau E; et al. (2003). "Cytotoxic T lymphocyte reactivity to gp100, MelanA/MART-1, and tyrosinase, in HLA-A2-positive vitiligo patients". J. Invest. Dermatol. 121 (3): 550–6. doi:10.1046/j.1523-1747.2003.12413.x. PMID 12925214.
  • Ghorab Z, Jorda M, Ganjei P, Nadji M (2004). "Melan A (A103) is expressed in adrenocortical neoplasms but not in renal cell and hepatocellular carcinomas". Appl. Immunohistochem. Mol. Morphol. 11 (4): 330–3. PMID 14663359.
  • Murer K, Urosevic M, Willers J; et al. (2005). "Expression of Melan-A/MART-1 in primary melanoma cell cultures has prognostic implication in metastatic melanoma patients". Melanoma Res. 14 (4): 257–62. PMID 15305155.
  • Gerhard DS, Wagner L, Feingold EA; et al. (2004). "The status, quality, and expansion of the NIH full-length cDNA project: the Mammalian Gene Collection (MGC)". Genome Res. 14 (10B): 2121–7. doi:10.1101/gr.2596504. PMID 15489334.
  • Kucher C, Zhang PJ, Pasha T; et al. (2005). "Expression of Melan-A and Ki-67 in desmoplastic melanoma and desmoplastic nevi". The American Journal of dermatopathology. 26 (6): 452–7. PMID 15618925.
  • Hoashi T, Watabe H, Muller J; et al. (2005). "MART-1 is required for the function of the melanosomal matrix protein PMEL17/GP100 and the maturation of melanosomes". J. Biol. Chem. 280 (14): 14006–16. doi:10.1074/jbc.M413692200. PMID 15695812.
  • Godefroy E, Scotto L, Souleimanian NE; et al. (2006). "Identification of two Melan-A CD4+ T cell epitopes presented by frequently expressed MHC class II alleles". Clin. Immunol. 121 (1): 54–62. doi:10.1016/j.clim.2006.05.007. PMID 16814609.
  • Kono M, Dunn IS, Durda PJ; et al. (2007). "Role of the mitogen-activated protein kinase signaling pathway in the regulation of human melanocytic antigen expression". Mol. Cancer Res. 4 (10): 779–92. doi:10.1158/1541-7786.MCR-06-0077. PMID 17050671.
  • Bioley G, Jandus C, Tuyaerts S; et al. (2007). "Melan-A/MART-1-specific CD4 T cells in melanoma patients: identification of new epitopes and ex vivo visualization of specific T cells by MHC class II tetramers". J. Immunol. 177 (10): 6769–79. PMID 17082590.
  • Roma AA, Magi-Galluzzi C, Zhou M (2007). "Differential expression of melanocytic markers in myoid, lipomatous, and vascular components of renal angiomyolipomas". Arch. Pathol. Lab. Med. 131 (1): 122–5. PMID 17227112.
  • Yuan F, Georgiou T, Hillon T; et al. (2007). "Crystallization and preliminary X-ray structural studies of a Melan-A pMHC-TCR complex". Acta Crystallogr. Sect. F Struct. Biol. Cryst. Commun. 63 (Pt 9): 758–60. doi:10.1107/S1744309107037244. PMID 17768347.

Template:WikiDoc Sources